Aankondiging • Jul 13
Delorean Corporation Ltd Receives $1.66 Million Third Grant Payment from Australian Renewable Energy Agency Delorean Corporation Ltd. has received the third cash payment milestone of $1.66 million exclusive of GST under an existing $7.74 million grant funding agreement with the Australian Government’s Australian Renewable Energy Agency. Total grant payments now received under the agreement are $5.46 million. The grant funding, provided under Australian Renewable Energy Agency’s National Industrial Transformation Program accelerates the development of Delorean’s SA1 Salisbury bioenergy facility, currently under construction in Edinburgh Parks, South Australia. The Australian Renewable Energy Agency grant payment funds Delorean for the costs of procurement, installation, and commissioning of critical infrastructure upgrades to enhance the facility’s ability to produce and upgrade biogas into mains-grade biomethane and biogenic CO2. This renewable gas will be supplied through the Adelaide gas network under a long-term offtake agreement. Aankondiging • Jun 23
Delorean Corporation Ltd Receives Additional AUD 1.66 Million Arena Grant For Sa1 Salisbury Facility Delorean Corporation Ltd. had been awarded an additional grant funding commitment of AUD 1.66 million exclusive of GST under its existing grant funding agreement with the Australian Government’s Australian Renewable Energy Agency for the SA1 Salisbury bioenergy facility, currently under construction in Edinburgh Parks, South Australia. This brings total ARENA support for the project, provided under ARENA’s National Industrial Transformation Program, to AUD 7.74 million, from the previously awarded AUD 6.08 million. The additional funding reflects unanticipated project scope refinements identified after execution of the original Funding Agreement and during progression into detailed design, procurement and construction. These refinements include upgrades to the facility’s biomethane production and gas injection systems, wastewater treatment infrastructure, biogenic CO2 recovery systems, and associated civil, engineering and compliance requirements. The enhanced scope reflects evolving regulatory, technical and offtake requirements that emerged during detailed design and project delivery. The ARENA grant payments fund Delorean’s costs to support the facility’s ability to meet the Project objectives to produce and upgrade biogas into mains-grade biomethane and biogenic CO2. Aankondiging • May 27
Delorean Corporation Limited has completed a Follow-on Equity Offering in the amount of AUD 0.750006 million. Delorean Corporation Limited has completed a Follow-on Equity Offering in the amount of AUD 0.750006 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 8,333,405
Price\Range: AUD 0.09 Aankondiging • May 02
Delorean Corporation Limited has completed a Follow-on Equity Offering in the amount of AUD 2.196 million. Delorean Corporation Limited has completed a Follow-on Equity Offering in the amount of AUD 2.196 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 24,400,000
Price\Range: AUD 0.09
Transaction Features: Subsequent Direct Listing Aankondiging • Apr 30
Delorean Corporation Limited has filed a Follow-on Equity Offering in the amount of AUD 6.60631 million. Delorean Corporation Limited has filed a Follow-on Equity Offering in the amount of AUD 6.60631 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 73,403,446
Price\Range: AUD 0.09 Reported Earnings • Oct 05
Full year 2025 earnings released: AU$0.041 loss per share (vs AU$0.022 profit in FY 2024) Full year 2025 results: AU$0.041 loss per share (down from AU$0.022 profit in FY 2024). Revenue: AU$19.5m (down 30% from FY 2024). Net loss: AU$8.98m (down 289% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Aankondiging • Oct 01
Delorean Corporation Limited, Annual General Meeting, Nov 28, 2025 Delorean Corporation Limited, Annual General Meeting, Nov 28, 2025. Reported Earnings • Aug 31
Full year 2025 earnings released: AU$0.03 loss per share (vs AU$0.022 profit in FY 2024) Full year 2025 results: AU$0.03 loss per share (down from AU$0.022 profit in FY 2024). Revenue: AU$20.4m (down 27% from FY 2024). Net loss: AU$6.55m (down 237% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Aankondiging • Mar 25
Delorean Corporation Limited Announces the Appointment of Aidan Flynn as Chief Financial Officer Delorean Corporation Limited announced the appointment of Mr. Aidan Flynn as Chief Financial Officer of the Company, following an extensive executive search and recruitment process. Aidan is the second senior executive to join the Company's leadership team this financial year. Aidan will lead and manage the finance function of the Company,including debt financing, treasury requirements, accounting and tax planning/compliance, cashflow management, corporate governance and risk management. Aidan brings over 25 years of comprehensive financial experience, including 18 years in CFO positions and extensive ASX experience blending technical, operational, and strategic acumen. He has a strong background in renewable energy and the construction industry and long standing roles of securing and supporting debt finance for growing companies. Aidan holds a Bachelor of Commerce(Accounting),a Bachelor of Science(Physics),a Post Graduate Diploma in Renewable Energy and a Graduate Diploma of Applied Corporate Governance. He is a Certified Practising Accountant(CPA) and is a Graduate of the Australian Institute of Company Directors(AICD). Reported Earnings • Mar 03
First half 2025 earnings released: EPS: AU$0.004 (vs AU$0.002 in 1H 2024) First half 2025 results: EPS: AU$0.004 (up from AU$0.002 in 1H 2024). Revenue: AU$12.3m (up 87% from 1H 2024). Net income: AU$978.0k (up 97% from 1H 2024). Profit margin: 8.0% (up from 7.5% in 1H 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. New Risk • Mar 01
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 55% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (AU$26.4m market cap, or US$16.4m). Aankondiging • Oct 10
Delorean Corporation Limited Appoints Michael Phillip as Non-Executive Director Delorean Corporation Limited advised that it has appointed Michael Phillip as a non-executive director of the Company. Michael is the founding Chief Investment Officer of Tanarra Capital's special situations division. He has
an extensive finance and credit investing background across various industries and continents including successful project financings of Australia's only geological hazardous waste repository and a WA lithium mine. Michael spent 14 years in Asia in investment banks and including 7 years as an Investment Manager with CarVal Investors prior to which he spent 5 years with Westpac in Australia. He has over 25 years of financial markets experience. Michael holds a Masters of Business Administration from the University of California at Berkeley and Bachelor of Engineering in Chemical Engineering from the University of Sydney. New Risk • Oct 08
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (26% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Market cap is less than US$100m (AU$30.8m market cap, or US$20.8m). Reported Earnings • Oct 02
Full year 2024 earnings released: EPS: AU$0.022 (vs AU$0.046 loss in FY 2023) Full year 2024 results: EPS: AU$0.022 (up from AU$0.046 loss in FY 2023). Revenue: AU$27.9m (up 45% from FY 2023). Net income: AU$4.77m (up AU$14.8m from FY 2023). Profit margin: 17% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Recent Insider Transactions Derivative • Oct 02
Co-Founder & Executive Chair exercised options to buy AU$273k worth of stock. On the 27th of September, Hamish Jolly exercised options to buy 2m shares at a strike price of around AU$0.20, costing a total of AU$456k. This transaction amounted to 5.1% of their direct individual holding at the time of the trade. Hamish currently holds 44.93m shares (0.20826200370974693 of the company). Company insiders have collectively bought AU$911k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Aug 31
Full year 2024 earnings released: EPS: AU$0.022 (vs AU$0.046 loss in FY 2023) Full year 2024 results: EPS: AU$0.022 (up from AU$0.046 loss in FY 2023). Revenue: AU$28.3m (up 47% from FY 2023). Net income: AU$4.77m (up AU$14.8m from FY 2023). Profit margin: 17% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Aankondiging • Oct 30
Delorean Corporation Limited, Annual General Meeting, Nov 30, 2023 Delorean Corporation Limited, Annual General Meeting, Nov 30, 2023, at 11:00 W. Australia Standard Time. Location: Level 31, Exchange Tower, 2 The Esplanade Perth Australia Agenda: To consider adoption of the Remuneration Report; to consider re-Election of Director Mr. Steve Gostlow; to consider Adoption of Employee Incentive Securities Plan; and to consider approval of 7.1A Mandate. Board Change • Sep 07
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Steve Gostlow was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.046 loss per share (vs AU$0.058 loss in FY 2022) Full year 2023 results: AU$0.046 loss per share (improved from AU$0.058 loss in FY 2022). Revenue: AU$19.7m (down 50% from FY 2022). Net loss: AU$10.0m (loss narrowed 8.0% from FY 2022). New Risk • Aug 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$9.4m free cash flow). Shares are highly illiquid. Earnings have declined by 67% per year over the past 5 years. Market cap is less than US$10m (AU$6.26m market cap, or US$4.01m). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Reported Earnings • Feb 25
First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.013 loss in 1H 2022) First half 2023 results: AU$0.005 loss per share (improved from AU$0.013 loss in 1H 2022). Revenue: AU$20.5m (up 16% from 1H 2022). Net loss: AU$1.12m (loss narrowed 51% from 1H 2022). Board Change • Nov 16
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Co-Founder, MD & Director Joe Oliver is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Oct 27
Delorean Corporation Limited, Annual General Meeting, Nov 30, 2022 Delorean Corporation Limited, Annual General Meeting, Nov 30, 2022, at 14:00 W. Australia Standard Time. Location: Level 32, Exchange Tower 2 The Esplanade Perth Western Australia Australia Agenda: To receive and consider the annual financial report for the Company for the financial year ended 30 June 2022 together which the declaration of the Directors, the Director's report, the Remuneration Report and the auditor's report; to consider Adoption of the Remuneration Report; to consider Re-election of Director - Mr. David McArthur; to consider Ratification of Prior Issue of Shares - LR 7.1 - Placement; to consider Ratification of Prior Issue of Shares - LR 7.1A - Placement; to consider Approval of Issue of Securities - Second Convertible Note; to consider Approval of 10% Placement Capacity; and to consider other matters. Reported Earnings • Oct 04
Full year 2022 earnings released: AU$0.058 loss per share (vs AU$0.038 loss in FY 2021) Full year 2022 results: AU$0.058 loss per share (further deteriorated from AU$0.038 loss in FY 2021). Revenue: AU$39.3m (up 41% from FY 2021). Net loss: AU$10.9m (loss widened 239% from FY 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Global Renewable Energy industry. Reported Earnings • Sep 01
Full year 2022 earnings released: AU$0.058 loss per share (vs AU$0.038 loss in FY 2021) Full year 2022 results: AU$0.058 loss per share (down from AU$0.038 loss in FY 2021). Revenue: AU$41.0m (up 47% from FY 2021). Net loss: AU$10.9m (loss widened 239% from FY 2021). Over the next year, revenue is forecast to grow 42%, compared to a 427% growth forecast for the Renewable Energy industry in Australia. Price Target Changed • Apr 27
Price target decreased to AU$0.20 Down from AU$0.27, the current price target is provided by 1 analyst. New target price is 21% above last closing price of AU$0.17. Stock is down 33% over the past year. The company posted a net loss per share of AU$0.038 last year. Board Change • Apr 27
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Co-Founder, MD & Director Joe Oliver is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 06
Full year 2021 earnings released: AU$0.037 loss per share The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$30.5m (down 2.4% from FY 2020). Net loss: AU$3.21m (down 224% from profit in FY 2020).